Skip to main content

Coronavirus outbreak

Researchers are trying to understand why vaccines are much less effective in the elderly than they are in the young. © Image Point Fr, Shutterstock
Vaccine potency drops in the elderly and little is known about why this happens. Now European scientists are on a mission to understand waning immunity and to develop strategies that make vaccines…
More than 99% of newly reported cases are attributed to the Delta variant. Credit © MIA Studio, Shutterstock
Since its emergence in March 2021, the Delta variant has rapidly become predominant across the European Union…
It is with an eye on the next pandemic that the European Union is proposing to create a Health Emergency Preparedness and Response Authority (HERA). Image credit - David Salamanca / Unsplash
The current pandemic caught the world off guard but there are more to come, and we need to work out how to…
Sometimes it can seem like we’ve uploaded our whole lives to the internet: bank accounts, social media posts, dating profiles, work emails – it’s all out there in that nebulous cloud of digital…
Viruses like Covid-19 make no distinction between those they infect. They should in theory cause disease in the rich just as they do the poor and pay no heed to social status or cultural background.…
Amid global vaccine rollouts, with nearly 1.2 billion doses currently administered, some countries have recommended a mixed-dose approach where a first prime shot is followed by a booster of a second…
The successful development of mRNA vaccines for Covid-19 is ‘transformational’ and opens the doors to new types of vaccines for other infectious diseases as well as cancer, according to Dr Özlem…
The speed with which coronavirus vaccines have been developed surprised everyone and could transform public health into the future, says Dr Fergus Sweeney, head of the clinical studies and…
The Sars-CoV-2 virus is changing in ways that are making it more transmissible, increasing the severity of disease it causes and allowing it to infect people who should have immunity. These variants…
A new antibody that can mount a double attack on the Sars-CoV-2 virus by binding to two different sites on the spike protein is starting human trials, leading to hopes of an antibody therapy that can…
Professor Johan Neyts, a virologist at the Rega Institute for Medical Research at KU Leuven in Belgium, leads a team searching for drugs that can help us in the fight against Covid-19. His laboratory…
Two anti-inflammatory drugs – tocilizumab and sarilumab – as well as steroids, have been identified as potential life-saving coronavirus treatments thanks to a trial set up in the wake of the 2009…
A mysterious flu-like illness that caused loss of taste and smell in the late 19th century was probably caused by a coronavirus that still causes the ‘common cold’ in people today, according to…